by David Koesters | Mar 25, 2019 | Blog |
Mohammed Lamorde, Infectious Diseases Institute, and Saye Khoo, University of Liverpool, discuss the Dolphin 2 Study, looking at Dolutegravir vs. Efavirenz based anti-retroviral therapy to reduce viral load of women in late...
by David Koesters | Mar 25, 2019 | Blog |
Meg Doherty, World Health Organization, talks with us at the 2019 Retrovirus Conference about some of the treatment and prevention approaches used around the world to try to attain the 90/90/90 targets as well as the need do more to take the public health approach to...
by David Koesters | Mar 25, 2019 | Blog |
Andy Kaytes interviews Jean-Michel Molina, ANRS-Ipergay Study, Université Paris 7, and Hopital Saint-Louis, about the safety of on-demand PrEP, and the issue of STIs in people using...
by David Koesters | Mar 25, 2019 | Blog |
Andy Kaytes interviews Win Min Han, HIV-NAT, Thai Red Cross AIDS Research Center, at the 2019 Retrovirus Conference in Seattle. As a young investigator, he is presenting two posters at the conference, about hepatitis C among men who have sex with men in Thailand who...
by David Koesters | Mar 25, 2019 | Blog |
Sharon Hillier, University of Pittsburgh School of Medicine, talks with us at the 2019 Retrovirus Conference in Seattle. “Men should think about their own reproductive health, as we see the reemergence of sexually transmitted infection, including...